Intervention with homoeopathy in the management of breast cancer patient in reference to quality of life
Phase 3
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2022/12/047852
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All types of Breast Cancer
Patients ready to sign the consent form
Exclusion Criteria
1. No male patients
2. No patients below the age of 18 years and above 75 years
3. Patients unwilling to sign the consent for
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5 month to collect the sample size and and then the cases will be followed every 2 weeks with Quality of life analysis over the period of one yearTimepoint: the effect of the interventional group will be assessed every 15 days or 2 weeks with QAL Br 30 over the period of 1 year
- Secondary Outcome Measures
Name Time Method made attempts at quantifying such changes <br/ ><br>towards improvement in quality of life in breast cancer patient <br/ ><br>Timepoint: the effects will be assessed on QAL Br 30 every 3month i.e 3rd month, 6 month , 9 month, and 12 month